Corvus Pharmaceuticals, Inc. (CRVS) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 239.95M | 58.21M | 66.94M | 75.78M | 45.49M | 54.41M | 42.92M | 48.26M | 22.85M | 27.96M | 33.09M | 37.91M | 35.55M | 43.66M | 51.27M | 58.88M | 64.37M | 71.31M | 78.76M | 69.12M |
| Cash & Short-Term Investments | 236.71M | 56.75M | 65.69M | 74.41M | 44.21M | 51.96M | 41.65M | 47.25M | 22.13M | 27.15M | 32.17M | 37.02M | 34.47M | 42.3M | 49.62M | 56.72M | 62.94M | 69.45M | 76.33M | 66.46M |
| Cash Only | 40.1M | 4.58M | 2.87M | 14.69M | 5M | 8.74M | 4.68M | 14.84M | 7.46M | 12.62M | 20.11M | 7.66M | 9.65M | 13.16M | 24.59M | 28.48M | 31.46M | 63.46M | 72.3M | 58.91M |
| Short-Term Investments | 196.61M | 52.17M | 62.82M | 59.72M | 39.21M | 43.22M | 36.97M | 32.41M | 14.67M | 14.53M | 12.06M | 29.36M | 24.81M | 29.14M | 25.03M | 28.25M | 31.48M | 5.99M | 4.03M | 7.54M |
| Accounts Receivable | 43K | 374K | 32K | 259K | 227K | 216K | 221K | 122K | 58K | 63K | 11K | 34K | 429K | 588K | 534K | 373K | 445K | 507K | 276K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.19M | 318K | 1M | 569K | 458K | 548K | 633K | 240K | 267K | 220K | 402K | 136K | 390K | 339K | 397K | 986K | 130K | 900K | 1.49M | 1.77M |
| Total Non-Current Assets | 13.25M | 12.9M | 13.53M | 13.68M | 13.95M | 14.5M | 15.89M | 16.3M | 17.23M | 17.6M | 18.85M | 20.13M | 22.65M | 24.58M | 29.08M | 33.66M | 36.92M | 38.14M | 40.57M | 40.27M |
| Property, Plant & Equipment | 1.03M | 1.06M | 1.15M | 1.26M | 1.26M | 1.33M | 455K | 770K | 1.08M | 1.39M | 1.69M | 1.99M | 2.28M | 2.57M | 2.91M | 3.24M | 3.32M | 3.64M | 3.96M | 1.91M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 10.5M | 10.99M | 11.53M | 11.79M | 12.06M | 12.54M | 15.19M | 15.4M | 16.07M | 16.12M | 17.07M | 18.02M | 20.23M | 21.88M | 25.91M | 30.18M | 33.37M | 34.27M | 36.33M | 38.05M |
| Other Non-Current Assets | 1.72M | 855K | 852K | 626K | 629K | 632K | 252K | 129K | 89K | 89K | 89K | 129K | 129K | 129K | 248K | 236K | 236K | 236K | 279K | 316K |
| Total Assets | 253.19M | 71.12M | 80.47M | 89.46M | 59.44M | 68.91M | 58.81M | 64.56M | 40.08M | 45.55M | 51.94M | 58.04M | 58.2M | 68.24M | 80.35M | 92.54M | 101.29M | 109.45M | 119.32M | 109.39M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 325.98% | 3.21% | 36.83% | 38.57% | 48.28% | 51.27% | 13.23% | 11.23% | -31.12% | -33.25% | -35.35% | -37.28% | -42.54% | -37.65% | -32.66% | -15.41% | -7.27% | 27.97% | 113.6% | 70.46% |
| Total Current Liabilities | 12.11M | 9.38M | 8.07M | 8.51M | 9.28M | 35.4M | 46.41M | 13.34M | 6.72M | 6.87M | 7.3M | 7.86M | 8.29M | 10.75M | 13.98M | 10.16M | 9.27M | 9.69M | 11.3M | 12.36M |
| Accounts Payable | 4.7M | 2.49M | 1.97M | 3.14M | 1.31M | 2.58M | 1.87M | 1.21M | 1.61M | 1.52M | 1.4M | 2.1M | 1.41M | 1.98M | 4.23M | 2.65M | 2.19M | 1.56M | 2.33M | 2.87M |
| Days Payables Outstanding | 11.15K | 7.9K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 428K | 403K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 0 | 0 | 1.18M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.99M | 5.84M | 566K | 1.17M | 4.8M | 30.02M | 40.98M | 7.35M | 768K | 929K | 262K | 3.66M | 379K | 158K | 7.23M | 131K | 1.15M | 121K | 130K | 283K |
| Current Ratio | 19.81x | 6.21x | 8.29x | 8.91x | 4.90x | 1.54x | 0.92x | 3.62x | 3.40x | 4.07x | 4.53x | 4.82x | 4.29x | 4.06x | 3.67x | 5.80x | 6.95x | 7.36x | 6.97x | 5.59x |
| Quick Ratio | 19.81x | 6.21x | 8.29x | 8.91x | 4.90x | 1.54x | 0.92x | 3.62x | 3.40x | 4.07x | 4.53x | 4.82x | 4.29x | 4.06x | 3.67x | 5.80x | 6.95x | 7.36x | 6.97x | 5.59x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 406K | 534K | 632K | 728K | 834K | 937K | 0 | 0 | 0 | 0 | 354K | 700K | 1.04M | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 631K |
| Long-Term Debt | 406K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 534K | 632K | 728K | 834K | 937K | 0 | 0 | 0 | 0 | 354K | 700K | 1.04M | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 631K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.52M | 9.91M | 8.71M | 9.23M | 10.11M | 36.34M | 46.41M | 13.34M | 6.72M | 6.87M | 7.65M | 8.56M | 9.33M | 12.13M | 15.67M | 12.15M | 11.57M | 12.29M | 14.18M | 12.99M |
| Total Debt | 834K | 937K | 1.01M | 1.08M | 1.15M | 1.12M | 354K | 700K | 1.04M | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 3.13M | 3.39M | 3.65M | 3.88M | 1.78M |
| Net Debt | -39.27M | -3.64M | -1.86M | -13.61M | -3.85M | -7.62M | -4.33M | -14.14M | -6.42M | -11.25M | -18.41M | -5.66M | -7.35M | -10.56M | -21.72M | -25.34M | -28.07M | -59.81M | -68.41M | -57.13M |
| Debt / Equity | 0.00x | 0.02x | 0.01x | 0.01x | 0.02x | 0.03x | 0.03x | 0.01x | 0.03x | 0.04x | 0.04x | 0.04x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -8.34x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1153.50x | -969.27x | - |
| Total Equity | 240.68M | 61.2M | 71.77M | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M | 33.36M | 38.68M | 44.29M | 49.48M | 48.87M | 56.12M | 64.68M | 80.39M | 89.72M | 97.16M | 105.15M | 96.4M |
| Equity Growth % | 387.95% | 87.93% | 478.35% | 56.62% | 47.84% | -15.81% | -71.98% | 3.52% | -31.72% | -31.06% | -31.53% | -38.44% | -45.54% | -42.25% | -38.49% | -16.61% | -4.94% | 34.67% | 148.28% | 89.62% |
| Book Value per Share | 2.67 | 0.77 | 0.87 | 1.03 | 0.66 | 0.48 | 0.19 | 0.86 | 0.68 | 0.79 | 0.90 | 1.04 | 1.05 | 1.21 | 1.39 | 1.73 | 1.93 | 2.09 | 2.39 | 2.28 |
| Total Shareholders' Equity | 240.68M | 61.2M | 71.77M | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M | 33.36M | 38.68M | 44.29M | 49.48M | 48.87M | 56.12M | 64.68M | 80.39M | 89.72M | 97.16M | 105.15M | 96.4M |
| Common Stock | 8K | 7K | 7K | 7K | 7K | 7K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K |
| Retained Earnings | -425.99M | -412.29M | -399.97M | -389.81M | -381.82M | -397.01M | -384.9M | -344.68M | -340.42M | -334.72M | -328.06M | -322.06M | -315.56M | -307.69M | -297.87M | -283.04M | -274.68M | -266.38M | -257.14M | -246.47M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.13M | -896K | -1.06M | -1.15M | -1.25M | -1.29M | -738K | -1.35M | -1.27M | -967K | -1.44M | -1.37M | -434K | -563K | -1.19M | 339K | 1.99M | 1.87M | 1.38M | 1.39M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |